To include your compound in the COVID-19 Resource Center, submit it here.

IMNX tumbles on clinical news

Immunex (IMNX) was off $7.25 (38 percent) to $11.625 on 93.9 million shares on Friday. The company announced

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE